Ferrari Richard M's Form 4 filing
Pulmonx Corp (LUNG) · filed Nov 10, 2022
- Accession no.
- 0001209191-22-056449
- Filed
- Nov 10, 2022
- Trade date
- Nov 8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $28.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ferrari Richard MCIK 0001034413 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | Common Stock | PPurchaseAcquired | +5,338 | $5.31 | +$28,344.78 | 29,935 | Direct | |
| Nov 8, 2022 | Common Stock | PPurchaseAcquired | +100 | $5.29 | +$529 | 30,035 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.